ImmunityBio (IBRX) Ownership
IBRX$6.22+0.24 +4.10%
Market cap$6.62BEnterprise value$10.20BRevenue (TTM)$165.79MMarket position—
Score
65
Bullish
Value
63
Quality
33
Growth
100
Ownership data loads after the page opens.
Ownership data loads after the page opens.
IBRX price $6.22 +0.24 +4.10%
Stocklytics score rationale: value 63, quality 33, growth 100.
AI Score 30. ImmunityBio, Inc. has a high market cap of approximately $9.46 billion but is facing significant financial challenges, with a net profit margin of -5.99% and a price-to-sales ratio of 57.1, indicating overvaluation relative to its revenue
Insights · Forecast · Financials · Learn